CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...